Central Airway Stenosis Clinical Trial
Official title:
Interventional Bronchoscopy Under Noninvasive Ventilation for Central Airway Stenosis
NCT number | NCT02289586 |
Other study ID # | szkcw-2014-322 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | August 4, 2014 |
Last updated | November 12, 2014 |
Start date | July 2014 |
To evaluate the effect and safety of noninvasive ventilation assisted interventional
bronchoscopy for hypoxemia patients with central airway stenosis.
With the sedation and analgesia, noninvasive ventilation assisted interventional
bronchoscopy for hypoxemia patients with central airway stenosis is safe and effective,
carries high satisfaction rate.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | |
Est. primary completion date | February 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - (a)patients with central airway stenosis need interventional bronchoscopy. (b) partial pressure of arterial oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio less than 300; Exclusion Criteria: - (a) facial deformity sufficient to preclude mask fitting; (b) upper gastrointestinal bleeding; (c) upper airway obstruction; (d) acute coronary syndromes; (e) tracheostomy or endotracheal intubation(ETI) before admission; (f) need for urgent ETI due to cardiac or respiratory arrest. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Futian People's Hospital | Shenzhen | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Futian People's Hospital | Science and Technology Innovation Commission of Shenzhen Municipality |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The improvement of airway stenosis after the operation | 1 day | No | |
Primary | The improvement of partial pressure of arterial oxygen (PaO2) after the operation | 1 day | No | |
Secondary | hospitalization expenses | During the period of hospitalization,an expected average of 4 weeks | No | |
Secondary | hypoxemia during the operation | 1 day | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02363959 -
Hyperbaric Oxygen Therapy for Lung Transplantation
|
Phase 2 | |
Completed |
NCT00672893 -
Vibration Response Imaging (VRI) in Patients That Are Undergoing Pulmonary Interventional Procedure
|
N/A |